Component
Sphingolipid excess in SPTLC1-ALS motor-neuron models
Context-specific entity; species, compartment and exposure are stated on each claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Adding excess serine further increased already elevated sphingolipid levels in mutant-SPTLC1 human iPSC-derived motor-neuron-like cells.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full-text results section: serine supplementation and ALS-associated SPTLC1 variants
- experimental_model
- Primary full-text experiment in engineered human motor-neuron-like cells.
- limitations
- Measured biochemical worsening is distinct from a clinical outcome trial; this finding cannot be generalized to all ALS.
- nutrient_topic
- L-Serine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Serine
- plain_language
- Extra substrate can feed an overactive pathway.
- primary_references
- Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34059824/ · DOI 10.1038/s41591-021-01346-1
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Serine: synthesis, one-carbon metabolism, lipids and cross-nutrient mechanisms (2026-09-19) · lines 318–324
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary full-text experiment in engineered human motor-neuron-like cells. · source_derived_draft · unverified_draft
## l-serine-als-serine-addition Extra substrate can feed an overactive pathway. Adding excess serine further increased already elevated sphingolipid levels in mutant-SPTLC1 human iPSC-derived motor-neuron-like cells. Model: Primary full-text experiment in engineered human motor-neuron-like cells. Limitations: Measured biochemical worsening is distinct from a clinical outcome trial; this finding cannot be generalized to all ALS. Evidence access: Primary full-text results section: serine supplementation and ALS-associated SPTLC1 variants Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34059824/ · DOI 10.1038/s41591-021-01346-1
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.